Skip to main content
HTFL
NASDAQ Industrial Applications And Services

Heartflow Q2 10-Q: 48% Revenue Growth, $7.5M Impairment, and New Insider Trading Plans

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Health Tech Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$35.97
Mkt Cap
$2.674B
52W Low
$20.13
52W High
$41.223
52W Position info
79% above low
Off High info
13% below high
Rel. Volume info
1.2× avg
Market data snapshot near publication time

HTFL sits 79% above its 52-week low of $20.13.

Summary

Heartflow's Q2 10-Q details 48% revenue growth to $64.1M, a $7.5M impairment charge, and new insider trading plans, while confirming raised full-year guidance.


Key Events · Earnings and Guidance · HTFL

  • Q2 Revenue Up 48%

    Revenue reached $64.1M for Q2 2026, up from $43.4M a year ago, driven by a 74% increase in revenue case volume and expanded reimbursement for Heartflow Plaque Analysis.

  • Full-Year Guidance Raised

    Management raised full-year 2026 revenue guidance to $246-$250M, up from prior expectations, reflecting continued commercial momentum.

  • $7.5M Asset Impairment

    The company recorded a $7.5M non-cash impairment charge in Q1 2026 related to subleasing its Mountain View facility at below-market rates.

  • New Insider Trading Plans

    CFO Vikram Verghese adopted a 10b5-1 plan on June 4, 2026 for up to 106,982 shares, and CMO Campbell Rogers adopted one on June 16, 2026 for up to 91,746 shares.


Analysis · HTFL · Industrial Applications And Services

Heartflow's Q2 10-Q confirms the strong revenue growth and raised guidance already announced in today's 8-K, but adds material new details: a $7.5 million asset impairment charge from subleasing its Mountain View facility, new 10b5-1 trading plans for the CFO and CMO, and ongoing DOJ and patent litigation disclosures. The company remains unprofitable with a $15.7M quarterly net loss, but holds $246.8M in cash and investments, providing runway for at least 12 months.

How filings like this one have moved

In the 30 days to Oct 22, 2026, 29.4% of the 1539 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.45%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, HTFL was trading at $35.97 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $2.7B. The 52-week trading range was $20.13 to $41.22. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

HTFL - Latest Insights

HTFL
Aug 28, 2026, 2:48 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $48.26
Real-time Price: $56.24 info
Change: +$7.98 (+17%) info
Market Cap: $4.89B info
HTFL
Aug 14, 2026, 4:58 PM EDT
Filing Type: 144
Importance Score:
7
Price at Filing: $41.88
Real-time Price: $56.24 info
Change: +$14.36 (+34%) info
Market Cap: $4.89B info
HTFL
Aug 14, 2026, 3:47 PM EDT
Source: Benzinga
Importance Score:
8
Price at Filing: $41.88
Real-time Price: $56.24 info
Change: +$14.36 (+34%) info
Market Cap: $4.89B info
HTFL
Aug 14, 2026, 3:29 PM EDT
Filing Type: 144
Importance Score:
7
Price at Filing: $42.16
Real-time Price: $56.24 info
Change: +$14.08 (+33%) info
Market Cap: $4.89B info
HTFL
Aug 13, 2026, 4:02 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $31.78
Real-time Price: $56.24 info
Change: +$24.46 (+77%) info
Market Cap: $4.89B info